Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2010
02/18/2010US20100041640 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
02/18/2010US20100041639 Cyclic malonamides as inhibitors of a beta protein production
02/18/2010US20100041638 Chemical Compounds 293
02/18/2010US20100041637 1,3-Oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11ß-hydroxysteroid dehydrogenase 1
02/18/2010US20100041636 Novel kinase inhibitors
02/18/2010US20100041635 Oxindole compounds
02/18/2010US20100041634 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
02/18/2010US20100041633 Nitric oxide releasing steroids
02/18/2010US20100041632 Uses of the carboxy-amido-triazole compounds and salts thereof
02/18/2010US20100041631 Methods and agents for treating tuberculosis
02/18/2010US20100041630 Methods for Treating or Preventing Inflammation Using a Glycerophosphate Salt
02/18/2010US20100041628 Novel indole derivative having ikappab kinase beta inhibitory activity
02/18/2010US20100041627 Compositions comprising polymeric emulsifiers and methods of using same
02/18/2010US20100041626 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
02/18/2010US20100041625 Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof
02/18/2010US20100041624 Buprenorphine formulations for intranasal delivery
02/18/2010US20100041623 Aqueous liquid preparation comprising gatifloxacin
02/18/2010US20100041622 Compositions containing aminoalkanes and aminoalkane derivatives
02/18/2010US20100041621 Methods and compositions for improving cognitive performance
02/18/2010US20100041620 Methods for improving frontal brain bioenergetic metabolism
02/18/2010US20100041619 Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders
02/18/2010US20100041618 6-11 Bridged Oxime Erythromycin Derivatives
02/18/2010US20100041617 Modulating mxa expression
02/18/2010US20100041616 Formulations for Nonsurgical Exogenous Crosslink Therapy
02/18/2010US20100041607 Unctuous compositions
02/18/2010US20100041592 Use of Amphiphilic Biocompatible Polymers for Solubilization of Hydrophobic Drugs
02/18/2010US20100041590 Compounds
02/18/2010US20100041587 Combination therapy for inhibition of platelet aggregation
02/18/2010US20100041151 Compositions and methods for treating lysosomal storage disease
02/18/2010US20100040710 Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers.
02/18/2010US20100040706 Method of anti-ageing cosmetic care by stimulation of survivin expression
02/18/2010US20100040697 Cosmetic product, nanoparticles for cosmetics, and powder for cosmetics
02/18/2010US20100040694 Low-molecular weight, water-soluble chitosan nanoparticle for gene delivery with folic acid conjugaed thereto as target ligand and preparation method thereof
02/18/2010US20100040692 Two phase bioactive formulations
02/18/2010US20100040691 Pharmaceutical compositions comprising methotrexate
02/18/2010US20100040690 Adhesive mixture for transdermal delivery of highly plasticizing drugs
02/18/2010US20100040689 Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
02/18/2010US20100040685 Collagen-based matrix for use as restorative material, and method for preparing the same
02/18/2010US20100040684 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
02/18/2010US20100040683 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
02/18/2010US20100040682 Fenofibrate tablets
02/18/2010US20100040681 Oral Sustained-Release Triple Layer Tablet
02/18/2010US20100040680 Multiparticulate selective serotonin and norepinephrine reuptake inhibitor formulation
02/18/2010US20100040679 Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage
02/18/2010US20100040678 Organic compounds
02/18/2010US20100040677 Formulations for benzimidazolyl pyridyl ethers
02/18/2010US20100040676 Polycistronic hiv vector constructs
02/18/2010US20100040674 Controlled delivery of bioactive agents from decomposable films
02/18/2010US20100040672 Delivery of therapeutics
02/18/2010US20100040670 Drug delivery via ocular implant
02/18/2010US20100040669 Non-Invasive Ocular Delivery of Rapamycin
02/18/2010US20100040668 Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
02/18/2010US20100040666 Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent
02/18/2010US20100040662 Fixation Devices For Tissue Repair
02/18/2010US20100040658 Antiviral composition and method of use
02/18/2010US20100040648 Plasmids with immunological action
02/18/2010US20100040643 Flavivirus immunogens and methods of use
02/18/2010US20100040641 Peptide vaccines for cancers expressing tumor-associated antigens
02/18/2010US20100040637 Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133)
02/18/2010US20100040632 Composition
02/18/2010US20100040628 Indoprofen derivatives for promoting bone growth
02/18/2010US20100040621 Novel polpeptide and use thereof
02/18/2010US20100040612 Methods and compositions for reducing amyloid beta levels
02/18/2010US20100040609 Methods for preventing, postponing or improving the outcome of invasive spinal procedures
02/18/2010US20100040607 Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases
02/18/2010US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
02/18/2010US20100040603 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
02/18/2010US20100040602 Antibodies against Human Cytimegalovirus (HCMV)
02/18/2010US20100040598 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
02/18/2010US20100040594 Formulations for nonsurgical exogenous crosslink therapy
02/18/2010US20100040593 Formulations for nonsurgical exogenous crosslink therapy
02/18/2010US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules
02/18/2010US20100040578 Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same
02/18/2010US20100040577 METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
02/18/2010US20100040575 Use of inhibitors of glutaminyl cyclase and glutamate cyclase for treatment and prevention of neurodegenerative diseases
02/18/2010US20100040573 Cationic polymers as thickeners for aqueous and alcoholic compositions
02/18/2010US20100040568 Steroidal compounds as melanogenesis modifiers and uses thereof
02/18/2010US20100040564 Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
02/18/2010US20100040561 Penetrating pharmaceutical foam
02/18/2010US20100040559 Use of a Pharmaceutical Composition Comprising an Anticholinergic for Killing Microorganisms and for Treating Respiratory Tract Infections
02/18/2010US20100040558 Green tea polyphenol alpha secretase enhancers and methods of use
02/18/2010US20100040557 Double-layered zaleplon- contained tablet
02/18/2010US20100040556 Carrier nanoparticles and related compositions, methods and systems
02/18/2010US20100040549 Composition for Targeted Drug Delivery and Controlled Release
02/18/2010US20100040548 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
02/18/2010US20100040538 Polymer Systems for Lung Volume Reduction Therapy
02/18/2010DE102008037790A1 Bicyclische Triazolderivate Bicyclic triazole derivatives
02/18/2010DE102008037324A1 Pharmazeutische Formulierung zur pulmonalen Blutdrucksenkung A pharmaceutical formulation for pulmonary blood pressure reduction
02/18/2010CA2770298A1 Glucagon antagonists
02/18/2010CA2737219A1 Halofuginone analogs for inhibition of trna synthetases and uses thereof
02/18/2010CA2735562A1 Organic compounds for wound healing
02/18/2010CA2735392A1 Bi-aryl aminotetralines
02/18/2010CA2734389A1 S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma
02/18/2010CA2734322A1 Na channels, disease, and related assays and compositions
02/18/2010CA2734305A1 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
02/18/2010CA2734225A1 Fluorescent regulators of rassf1a expression and human cancer cell proliferation
02/18/2010CA2734191A1 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof
02/18/2010CA2734179A1 Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma
02/18/2010CA2734119A1 Two phase bioactive formulations
02/18/2010CA2734104A1 Substituted aminotetralines
1 ... 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 2398 ... 7860